Costs of Antifungal Prophylaxis After Bone Marrow Transplantation
- 1 October 1995
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 8 (4) , 350-361
- https://doi.org/10.2165/00019053-199508040-00009
Abstract
The costs per successfully treated patient over a 12-week period were £28 956 (£1 = $US 1.60, June 1995) for oral fluconazole, £53 225 for liposomal amphotericin and £32 768 for oral polyenes. Sensitivity analysis showed that the costs of liposomal amphotericin always exceeded those of the oral comparators, reflecting its high acquisition, preparation and administration costs.Keywords
This publication has 17 references indexed in Scilit:
- Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.1993
- Antifungal Prophylaxis in Immunocompromised HostsAnnals of Pharmacotherapy, 1993
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Pharmacoeconomics of Intravenous Drug AdministrationPharmacoEconomics, 1992
- Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?Chemotherapy, 1992
- Successful Treatment of Fungal Infections in Neutropenic Patients with Liposomal Amphotericin (AmBisome)—A Report on 40 Cases from a Single CentreLeukemia & Lymphoma, 1992
- Cost Effectiveness of Bone Marrow Transplantation in Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1989
- Current status of bone marrow transplantation.1989
- Infectious Complications in Adults with Bone Marrow Transplantation and T-Cell Depletion of Donor MarrowAnnals of Internal Medicine, 1986
- Chemoprophylaxis of fungal infectionsThe American Journal of Medicine, 1984